Clinical trial
Validation of AKI-Sapere Model to Predict Patients at Risk for AKI After Cardiac Surgery: GUARD-AKI (GUiding Against Reserve Decline)
NCT03635606 is registered in ClinicalTrials.gov with Sapere Bio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of AKI-Sapere Model to Predict Patients at Risk for AKI After Cardiac Surgery: GUARD-AKI (GUiding Against Reserve Decline)
- Lead sponsor
- Sapere Bio
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 24, 2020
- Completion date
- February 28, 2023
- Enrollment
- 370 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.